NIH Marks $275M for Rare Disease and Extracellular RNA Studies | GenomeWeb

NEW YORK (GenomeWeb News) – The National Institutes of Health has pledged $275 million to fund two multi-year research programs, including studies to discover the causes and cures for rare diseases and how extracellular RNA is involved in disease, NIH said today.

The new strategic funding from NIH's Common Fund includes $145 million for the Undiagnosed Diseases Program, or UDP, and $130 million for the Extracellular RNA Communication program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.